Rights and permissions
About this article
Cite this article
Esorubicin: fails to be beneficial in patients with advanced sarcoma. Inpharma Wkly. 704, 5 (1989). https://doi.org/10.1007/BF03319228
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03319228